PANTHERx Rare
  • Patient Portal
  • Menu
Close
  • Patients
  • Biopharma
  • Payer
  • Prescribers

Browse By

  • Rare Disorders
  • Our Purpose
  • What We Do
  • Company
  • Leadership
  • Education
  • Resources
  • Careers
  • Blog
  • Contact

Give us a call

  • 855.726.8479
  • 412.246.9858

Follow Us on Social Media

  • Facebook
  • Twitter
  • YouTube
  • LinkedIn
Blog

Blog

PANTHERx® Selected by UCB as part of the Limited Specialty Pharmacy Network for RYSTIGGO®(rozanolixizumab-noli),  for the Treatment of Generalized Myasthenia Gravis (gMG)

Posted on August 2, 2023

PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce it has been selected by UCB as a …

Read More

PANTHERx Rare Announces Exciting Leadership Changes: New President and Key Hire

Posted on June 20, 2023

PITTSBURGH, June 21, 2023 /PRNewswire/ — PANTHERx Rare, the nation’s leading rare disease pharmacy, is excited to announce significant leadership changes as part of its ongoing growth and strategic development. …

Read More

PANTHERx Rare Pharmacy Expands Services to Include Dispensing AYVAKIT® (avapritinib) for the Expanded Approval for Treatment of Indolent Systemic Mastocytosis (ISM).

Posted on June 19, 2023

Blueprint Medicines recently announced the approval of AYVAKIT® (avapritinib) for the expanded indication of adults with Indolent Systemic Mastocytosis (ISM). AYVAKIT was previously approved for the treatment of adults with …

Read More

PANTHERx® Rare Announces Partnership with Biocodex for the Distribution of DIACOMIT® (stiripentol) for the Treatment of Seizures Associated with Dravet Syndrome in Patients 2 Years of Age and Older Taking Clobazam

Posted on June 27, 2022

Read the Official PANTHERx Press Release. PANTHERx Rare announces that it has been selected by Biocodex as their new exclusive U.S. pharmacy distribution partner for DIACOMIT® (stiripentol). DIACOMIT is a …

Read More

New Article from PANTHERx Explores Best-in-Class Approach to Improve Services for Patients Living with Rare Disease

Posted on June 7, 2022

As a five-time MMIT Patient Choice Award Winner with a portfolio of 25+ rare programs, PANTHERx attributes much of our success to our ability to hire and cultivate talent while …

Read More

Q1 2022: PANTHERx Earns #1 Ranking in Quarterly MMIT Patient Satisfaction Survey

Posted on June 3, 2022

PANTHERx Rare Pharmacy is proud to have again earned the #1 ranking in the quarterly patient satisfaction survey conducted by MMIT, an independent national survey entity. For the first quarter of …

Read More

PANTHERx Rare Celebrates Fifth Patient Choice Award Win

Posted on May 4, 2022

Read the Official PANTHERx Press Release. For a fifth time, PANTHERx Rare has been recognized as the winner of the annual, Specialty Pharmacy Patient Choice Award™. Since 2016, the Managed …

Read More

New Article from PANTHERx Examines the Evolution of Specialty Pharmacy Channel Strategy

Posted on April 21, 2022

Change has been a constant in the specialty pharmacy industry since its inception over two decades ago. New medications are routinely launched, more patient populations receive treatment, and public awareness …

Read More

Celebrating Rare Disease Day, Today & Every Day

Posted on February 28, 2022

The History of Rare Disease Day On February 29th, 2008, EURORDIS, a non-profit patient alliance of now nearly one thousand organizations from 73 countries, celebrated the first Rare Disease Day …

Read More

PANTHERx® Rare Selected by Aadi Bioscience to Distribute FYARRO™ (sirolimus protein-bound particles for injectable suspension) (albumin-bound) for advanced malignant perivascular epithelioid cell neoplasm (PEComa)

Posted on February 24, 2022

Read the Official PANTHERx Press Release. PANTHERx Rare announces that it has been selected by Aadi Bioscience as the exclusive U.S. pharmacy distribution partner for new drug FYARRO™ (sirolimus protein-bound …

Read More
  • 1
  • 2
  • 3
  • 4
  • …
  • 18
  • Next >

Categories

  • Industry News
  • Blog
  • Press Releases

Archives

PANTHERx Rare

Connect

Follow Us on Social Media

  • Facebook
  • Twitter
  • YouTube
  • LinkedIn

PANTHERx Rare

24 Summit Park Drive | Pittsburgh, PA 15275 USA

Phone: 855.726.8479 (412.246.9858)

Fax: 855.246.3986 (412.787.9400)

Email: pharmacist@pantherxrare.com

  • Patients
  • Prescribers
  • Blog
  • Twilio SMS Terms & Conditions
  • Privacy Policy
  • Legal Disclosure

Copyright © 2023 PANTHERx Rare, LLC. All rights reserved.

PANTHERx RARE PHARMACY, "REINVENTING PHARMACY, REVOLUTIONIZING SPECIALTY, REDEFINING CARE", and THE RARE DISEASE SP are registered service marks of PANTHERx Rare, LLC.

Website by Imagebox